Table 2.
Changes in biochemical characteristics of study participants post intervention.
| Parameters | All (N = 120) | Males (N = 58) | Females (N = 62) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Follow-Up | Difference | p-Value | Follow-Up | Difference | p-Value | Follow-Up | Difference | p-Value | |
| Total cholesterol (mmol/L) # | 5.1 ± 1.3 | −0.02 | 0.83 | 5.2 ± 1.4 | 0.1 | 0.46 | 5.0 ± 1.2 | −0.1 | 0.31 |
| Triglycerides (mmol/L) $ | 1.6 (1.1,2.1) | 0.1 | 0.82 | 1.7 (1.3,2.3) | 0.2 | 0.60 | 1.4 (1,2) | −0.1 | 0.40 |
| HDL cholesterol (mmol/L) # | 1.1 ± 0.4 | 0.1 | 0.001 | 1.0 ± 0.3 | 0.1 | 0.001 | 1.2 ± 0.4 | 0.2 | 0.04 |
| LDL cholesterol (mmol/L) # | 3.1 ± 1.1 | −0.1 | 0.28 | 3.2 ± 1.3 | 0.1 | 0.65 | 3.1 ± 1 | −0.2 | 0.04 |
| Glucose (mmol/L) $ | 5.8 (5.2,6.4) | 0.1 | 0.62 | 5.9 (5.5,6.4) | 0.2 | 0.24 | 5.5 (4.8,6.4) | −0.1 | 0.74 |
| Total 25 (OH)D (nmol/L) # | 63.3 ± 16.5 | 30.8 | <0.001 | 61 ± 14.3 | 26.2 | <0.001 | 65.5 ± 18.1 | 35.1 | <0.001 |
| ASCVD risk score (%) $ | 5.0 (1.5,8.3) | −1.1 | <0.001 | 7.4 (5.4,12) | −1.4 | 0.02 | 1.5 (0.8,3.5) | −1.1 | <0.001 |
Note: Data presented as mean ± SD for continuous normal variables (#); and medians (25th percentile, 75th percentile) for continuous non-normal variables ($). The difference between variables post intervention versus baseline was calculated by related samples t-test and Wilcoxon matched-pair signed rank test for Gaussian and non-Gaussian variables, respectively. p < 0.05 is considered significant.